The tight link between CRISP3 expression, ERG gene rearrangements and/ or PTEN deletions in the three cohorts of prostate cancer studied, suggest the presence of distinct molecular alterations in this subgroup of tumors that may have additional clinical implication if assessed collectively. The gene discussed is CRISP3; the disease is prostate carcinoma.